- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Flupirtine.
Displaying page 1 of 1.
EudraCT Number: 2005-002959-41 | Sponsor Protocol Number: FLUPI-5014 | Start Date*: 2005-10-10 |
Sponsor Name:AWD.pharma GmbH & Co. KG; Medical Development | ||
Full Title: A multicentre, double-blind, randomised, placebo-controlled clinical trial to investigate pain relieving effects of the modified release (MR) formulation of flupirtine in patients suffering from mo... | ||
Medical condition: chronic low back pain | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-013268-38 | Sponsor Protocol Number: FLUPI-7018 | Start Date*: 2009-09-29 | |||||||||||
Sponsor Name:AWD.pharma GmbH & Co KG | |||||||||||||
Full Title: A multicentre, double-blind, randomised, active- and placebo-controlled clinical trial on the pain relieving effects of the modfied-release formulation of flupirtine in patients suffering from mode... | |||||||||||||
Medical condition: chronic low back pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004854-26 | Sponsor Protocol Number: ELB245201-06 | Start Date*: 2007-02-16 | |||||||||||
Sponsor Name:elbion AG | |||||||||||||
Full Title: A multicenter, randomized, double-blind, parallel group, phase II, forced dose titration study to investigate the efficacy and safety of 400mg and 600mg flupirtine (ELB245) given once daily for 12 ... | |||||||||||||
Medical condition: Incontinent Overactive Bladder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) SE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001202-99 | Sponsor Protocol Number: CNSB015CP01 | Start Date*: 2011-10-18 | |||||||||||
Sponsor Name:Relevare Pharmaceuticals, Ltd. | |||||||||||||
Full Title: A Phase IIb/III, Double-Blind, Placebo-Controlled, Randomized Study Investigating the Safety, Tolerability and Efficacy of Flupirtine as Adjunct to Opioids When Administered to Cancer Subjects Who ... | |||||||||||||
Medical condition: Pain with neuropathic features in cancer subjects which is inadequately controlled despite optimized opioid treatment | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
